Position
SYNTAX RESEARCH, INC. in Medtronic Plc
Back to the book · All holders of MDT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$60.6K$96.06 → $86.65
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.98K | $670.4K | — | — | — | 0.4% |
| Q1 2026 | 6.44K | $558K | $86.65 | −$60.6K | −$51.8K | 0.4% |